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A common T/A polymorphism (rs9939609) in the fat mass and obesity associated (FTO) gene was found associated with early-
onset and severe obesity in both adults and children. However, recent observations failed to ﬁnd associationsof FTO with obesity.
Toinvestigatethegeneticbackgroundofearlyobesity,weanalysedthesinglenucleotide polymorphism(SNP)rs9939609ofFTOin
371 styrian adolescents towards degree of obesity, subcutaneous adipose tissue (SAT)-distribution determined by lipometry, early
metabolic and preatherosclerotic symptoms. The percentage of AA homozygotes for the rs9939609 SNP of FTO was signiﬁcantly
increased in the obese adolescents. Compared to the TT wildtype, AA homozygotes showed signiﬁcantly elevated values of SAT
thickness at the trunk-located lipometer measure points neck and frontal chest, body weight, body mass index, waist, and hip
circumference. No associations were found with carotis communis intima media thickness, systolic, diastolic blood pressure,
ultrasensitive C-reactive protein (US-CRP), homocystein, total cholesterol, triglycerides, HDL cholesterol, oxidized LDL, fasted
glucose,insulin,HOMA-index, liver transaminases,uric acid,andadipokines likeresistin,leptin, andadiponectin. Takentogether,
to the best of our knowledge we are the ﬁrst to report that the rs9939609 FTO SNP is associated with trunk weighted obesity as
early as in adolescence.
1.Introduction
Juvenile obesity usually leads to obesity in adulthood which
causes life threatening sequels such as diabetes, cardiovascu-
lar disease, hypertension, stroke,and cancer [1].Inforegoing
studies, we detected an increased carotid intima-media
thickness (IMT) paralleled by a subclinical inﬂammation
in obese adolescents and we provided the ﬁrst evidence
that preatherosclerosis is associated with individual risk
proﬁles characterised by subcutaneous adipose tissue (SAT)
topography and altered biomarkers [2–4]. In this paper,
we analysed the single nucleotide polymorphism (SNP)
rs9939609 of the fat mass and obesity-associated (FTO) gene
inobese styrian adolescentsandin normal weight controlsof
the same age and gender distribution. FTO is a gene located
inchromosome region16q12.2.Recently,itwasbroughtinto
connection with the central control of energy homeostasis
and fat cell lipolysis [5, 6]. The single-nucleotide polymor-
phisms (SNPs) rs1421085, rs17817449, and rs9939609, of
FTO were reported to be linked to body mass index (BMI)
and obesity in both adults and children [7–9]. However,
Li et al. failed to ﬁnd associations of FTO with obesity
[10]. To clarify this issue, we examined the so far best
described FTO gene variant (i.e., SNP rs9939609) [6, 8]f o r
correlations with grade of obesity, SAT distribution, and
obesity-related metabolicand cardiovascularrisk parameters
in styrian adolescents.
2.Materialand Methods
2.1. Subjects. Study participants (obese persons and normal
weight, age- and sex-matched controls) were from the
STYrian Juvenile OBesity Study (STYJOBS), which is2 Journal of Obesity
Table 1: Baseline characteristics of study participants (age range
5t o2 0y e a r s ,n = 371).
Variable Normal weight (mean+1SD) Obese
Individuals 103 268
Female/male 51/52 146/122
Age (years) 14.0 ±3.11 2 .5 ± 3.1
Body length (m) 1.6 ±0.12 1.6 ±0.15
Body weight (kg) 54.0 ±13.67 6 .2 ±26.0
BMI (kg/m2)2 0 .0 ±2.93 0 .1 ± 6.2
BMI-SDS 0.3 ±1.06 .0 ±2.6
BMI: body mass index.
BMI-SDS: body mass index standard deviation score.
Table 2: Occurrence of the rs9939609 FTO gene polymorphism
within the experimental groups.
FTO
rs9939609
genotypes
Normal weight
adolescents
(n = 103)
Obese
adolescents
(n = 268)
P value
TT 31 (30.1%) 75 (27.9%)
TA 56 (54.3%) 118 (44.0%)
AA 16 (15.5%) 75 (27.9%) .015 (AA versus
TT&TA)
A allele
frequency 0.427 0.500 .075
designed to investigate early stages of atherosclerosis and
metabolic disorders in obese juveniles. STYJOBS is regis-
tered at Clinical-Trials.gov (Identiﬁer NCT00482924),where
detailed infor-mation of the study is available. The inclusion
criterium for the obese probands was BMI >97th percentile
if under 18 years of age, BMI >30kg/m2 if over 18 years
of age. Exclusion criteria were endocrine diseases (e.g.,
hypothyreosis), infectious or any other chronic diseases.
Further, STYJOBS participants aged above 20 years were
excluded in this study. Controls were healthy age-matched
volunteers. All controls had to be normal weight (BMI
around 50th percentile if under 18 years of age, BMI
<25kg/m2 i fo v e r1 8y e a r so fa g e )f r e eo fi n f e c t i o u s ,c h r o n i c ,
and endocrine diseases. 268 obese juveniles recruited from
July 2003 to December 2006 (mean age 12.5 ± 3.1 (SD)
years) and 103 normal weight healthy controls of similar
age and gender distribution were investigated. The study was
approved by the ethical committee of the Medical University
of Graz. At the time of blood collection, the probands
were fasting. Blood samples were immediately centrifuged at
3500rpm at ambient temperature and stored at −80◦Cu n t i l
analysis.
2.2. Laboratory Analysis. Genomic DNA was isolated from
peripheral lymphocytes by standard methods and stored at
−20◦C. FTO genotypes were determined by 5 -exonuclease
assay (TaqMan, Applied Biosystems, Applera International
Inc., Austria GmbH, Mahlerstrasse 13, A-1010 Vienna, Aus-
tria).Primerandprobesetsweredesignedandmanufactured
using Applied Biosystems “Assay-by-Design” custom service
(Applied Biosystems, Applera International Inc., Austria
GmbH, Mahlerstrasse 13, A-1010 Vienna, Austria), and
assays were performed according to the manufacturer’s in-
structions. End-point ﬂuorescence was measured and ﬂu-
orescence plate reader data were exported into an Excel
format, depicted, and analyzed as a scatter plot.
Liver transaminases, creatinine, glucose and uric acid
were measured by routine laboratory methods on a Hitachi
917 chemical analyser, cholesterol and triglyceridesby means
of ECLIA (ElectroChemiLuminiscenceAssay) on an Elecsys
2010 analyser (Roche Diagnostics Mannheim, Germany),
and plasma insulin by ELISA (Mercodia, Uppsala, Swe-
den). HOMA-IR (homeostatic model assessment-insulin
resistance) was calculated as reported [11]. Lipoproteins
were separated by a combined ultracentrifugation-precipi-
tation method (β-quantiﬁcation) and analysed as outlined
elsewhere [12]. Total adiponectin and subfractions were
determined by Adiponectin (Multimeric) Enzyme-Linked
ImmunoSorbent Assay (47-ADPH-9755) from Alpco Diag-
nostics, leptin and resistin by ELISAs from Biovendor Labo-
ratory Medicine, Inc. (Brno, Czech Republic), oxidized low
dense lipoprotein (oxLDL) by Mercodia oxidized LDL Com-
petitive ELISA, SE-754 50 Uppsala, Sweden, ultra sensitive-
CRP with a particle-enhanced immunoturbidimetric assay
(Tina-quant C-reactive protein latex ultrasensitive assay,
Roche diagnostics), homocysteine by triple quadrupolemass
spectrometry (Applied biosystems, API 2000 LC/MS/MS-
system) using a 3.3 × 0.46cm HPLC column (SUPELCO
LC-CN).
2.3. Carotid Artery Ultrasound. The ultrasound protocol
involved scanning of the bulbous near the common carotid
artery (CCA) on both sides with a 12-to-5-MHz broad-
band linear transducer on an HDI 5000 (ATL, Bothell,
Washington, DC, USA). The carotid IMT was assessed at
the far wall as the distance between the interface of the
lumen and intima and the interface between the media and
adventitia. All diameters were measured during diastole to
avoid image blurring due to systolic arterial wall motion and
to minimize the inﬂuence of blood pressure [13].
2.4. Lipometry. Measurements of SAT thickness were per-
formed by means of a patented optical device (EU Pat.Nr.
0516251) on 15 anatomically well-deﬁned body sites dis-
tributed from neck to calf on the right and left side of all
obese juveniles [14] and then averaged for both body sides.
2.5. Statistics. Statistical analysis was performed by SPSS
version 14. Kolmogorov-Smirnov test was used to examine
for normal distribution. Means were compared by a two-
tailed unpaired sample t-test or by Mann-Whitney Test,
depending on the distribution of the data. A value of P<. 05
was considered statistically signiﬁcant.
3.Results
The clinical characteristics of the study participants are
summarized in Table 1. FTO genotypes did not deviate fromJournal of Obesity 3
Table 3: Associations of clinical parameters with the rs9939609 FTO gene polymorphism.
Mean + 1SD Wildtype Heterozygote Homozygote
Body weight (kg) 65.9 ±23 70.4 ±26.47 4 .2 ±25
∗∗
BMI (kg/m2)2 6 .5 ±72 7 .7 ±7.22 8 .8 ±7∗∗
BMI-SDS 4.2 ±3.54 .2 ±3.45 .1 ±3.5
∗
Waist circumference (cm) 85.4 ±16 88.1 ±16.89 0 .4 ±13
∗
Hip circumference (cm) 99.7 + 16 102.9 ±16.9 105.1 ±16
∗
SAT-T, neck (cm) 12.7 ±6.51 3 .9 ±71 5 .3 ±5.8
∗∗
SAT-T, front chest (cm) 16.7 ±8.91 8 .4 ±8.82 0 .4 ±9.3
∗∗
∗P<. 05, ∗∗P<. 01, ∗∗∗P<. 001, MannWhitney U-test (wildtype versus homozygote).
BMI: Body mass index.
BMI-SDS: body mass index standard deviation score.
Table 4: Clinical parameters and the rs9939609 FTO gene polymorphism within all experimental groups.
Obese adolescents Normal weight adolescents
Mean + 1SD Wildtype
n = 75
Heterozygot
n = 118
Homozygote
n = 75
Wildtype
n = 31
Heterozygote
n = 56
Homozygote
n = 16
Body weight (kg) 72.1 ±23.37 7 .8 ± 27.77 7 .9 ±25.75 1 .1 ±12.75 4 .8 ± 13.95 6 .8 ±13.5
BMI (kg/m2)2 9 .3 ±6.13 0 .3 ± 6.33 0 .6 ±6.11 9 .5 ±2.82 0 .2 ± 2.82 0 .3 ±3.3
BMI-SDS 5.9 ±2.66 .0 ± 2.66 .2 ±2.90 .17 ±0.90 .4 ± 1.00 .2 ±1.0
Waist circumference (cm) 89.9 ±14.89 2 .2 ± 15.89 2 .7 ±11.86 7 .9 ±5.87 0 .8 ± 6.37 1 .6 ±7.4
Hip circumference (cm) 102.8 ±15.8 106.4 ± 16.5 106.7 ±16.48 7 .6 ±8.98 8 .5 ± 8.99 2 .6 ±11.1
SAT-T, neck (cm) 14.3. ± 5.71 5 .4 ± 6.41 5 .6 ±5.15 .3 ±4.55 .9 ± 4.55 .6 ±3.6
SAT-T, front chest (cm) 19.9. ± 7.42 0 .8 ± 8.12 2 .3 ±9.45 .4 ±4.57 .5 ± 5.48 .2 ±7.1
BMI: body mass index.
BMI-SDS: body mass index standard deviation score.
the Hardy-Weinberg equilibrium. Compared to the normal
weight controls, the percentage of carriers of the FTO AA
genotype was signiﬁcantly increased in the obese ado-
lescents (Table 2). Heterozygous and wildtype genotypes
were approximately equally distributed within the groups
(Table 2).
Homozygotecarriersshowed signiﬁcantlyelevatedvalues
for body weight, body mass index (BMI), BMI standard
deviation scores (BMI-SDS), and waist, hip circumferences,
and the thickness of the SAT was signiﬁcantly increased at
thetrunk-locatedlipometermeasurepoints,neckandfrontal
chest (Table 3). Analysed separately in the obese and normal
weight group, these variables showed a trend to higher levels
inheterozygoteandhomozygotecarriers;howevernosigniﬁ-
cantdiﬀerencewasachieved(Table4).Further,nosigniﬁcant
elevations were found with carotis IMT, systolic, diastolic
blood pressure, US-CRP, homocystein, total cholesterol,
triglycerides, HDL cholesterol, oxidized LDL, fasted glucose,
insulin, HOMA-index, liver transaminases, uric acid, and
adipokines (Resistin, leptin, adiponectin, and subfractions)
either in the homozygote nor in the heterozygote carriers
(not shown).
4.Discussion
We analysed the single nucleotide polymorphism (SNP)
rs9939609 of the FTO gene in obese Caucasian adolescents
and in normal weight controls of the same age and gender
distribution. The percentage of AA homozygotes for the
rs9939609 SNP of FTO was signiﬁcantly increased in the
obese adolescents indicating a relevance of this SNP in early
phasesofobesity.TheobservationthattheSATthicknessesof
thetrunk-locatedlipometermeasurepoints,neckandfrontal
chest, were signiﬁcantly increased in homozygote rs9939609
carriers indicates for the ﬁrst time a link between trunk-
weighted SAT distribution and a speciﬁc genetic disposition.
On the other hand, no associations could be found
betweentheinvestigatedSNPandcardiovascular riskparam-
eters like carotis communis IMT, systolic, diastolic blood
pressure, conventional laboratory-, metabolic-, inﬂamma-
torybiomarkers(e.g.,Liverenzymes, fasted glucose,HOMA-
index, homocystein, lipids, oxidizedLDL,and US-CRP),and
adipokines such as adiponectin, resistin, and leptin. This
may be caused by the fact that these cardiovascular and
metabolic risk parameters reﬂect a more common patho-
logic phenotype. Genetic risk constellations, possibly more
importantforfutureclinicalendpoints,maybepresentinthe
background without correlation to these markers but related
to trunk-weighted obesity. It will be interesting to follow up
thiscohortofadolescentsfordevelopmentofovertmetabolic
and atherosclerotic disease symptoms later in life and to
study correlations of clinical end points with homozygote
rs9939609 carriers.
Several studies reported a strong link between the
rs1421085, rs17817449, and rs9939609 SNPs of FTO and
body mass index (BMI),eveninchildren [7–9].Onthe other4 Journal of Obesity
hand, a recent study failed to ﬁnd associations of FTO with
obesity [10]. This may be inﬂuenced be the fact that these
authors investigated Chinese and not Csaucasion probands
[10]. Our observations in juveniles are in accordance with
the observations of adults by Frayling et al. [8].
Taken together, to the best of our knowledge, we are the
ﬁrst to report that homozygosity for the rs9939609 FTO SNP
is critically associated with trunk-weighted obesity in obese
adolescents.
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